1. Home
  2. CLLS vs TSQ Comparison

CLLS vs TSQ Comparison

Compare CLLS & TSQ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CLLS
  • TSQ
  • Stock Information
  • Founded
  • CLLS 1999
  • TSQ 1996
  • Country
  • CLLS France
  • TSQ United States
  • Employees
  • CLLS N/A
  • TSQ N/A
  • Industry
  • CLLS Biotechnology: Pharmaceutical Preparations
  • TSQ Broadcasting
  • Sector
  • CLLS Health Care
  • TSQ Consumer Discretionary
  • Exchange
  • CLLS Nasdaq
  • TSQ Nasdaq
  • Market Cap
  • CLLS 143.4M
  • TSQ 120.0M
  • IPO Year
  • CLLS 2007
  • TSQ 2000
  • Fundamental
  • Price
  • CLLS $2.95
  • TSQ $6.85
  • Analyst Decision
  • CLLS Buy
  • TSQ Buy
  • Analyst Count
  • CLLS 1
  • TSQ 1
  • Target Price
  • CLLS $4.00
  • TSQ $13.00
  • AVG Volume (30 Days)
  • CLLS 310.2K
  • TSQ 83.7K
  • Earning Date
  • CLLS 08-04-2025
  • TSQ 08-06-2025
  • Dividend Yield
  • CLLS N/A
  • TSQ 11.59%
  • EPS Growth
  • CLLS N/A
  • TSQ N/A
  • EPS
  • CLLS N/A
  • TSQ N/A
  • Revenue
  • CLLS $54,747,000.00
  • TSQ $450,024,000.00
  • Revenue This Year
  • CLLS N/A
  • TSQ N/A
  • Revenue Next Year
  • CLLS $4.90
  • TSQ $6.28
  • P/E Ratio
  • CLLS N/A
  • TSQ N/A
  • Revenue Growth
  • CLLS 351.26
  • TSQ N/A
  • 52 Week Low
  • CLLS $1.10
  • TSQ $6.47
  • 52 Week High
  • CLLS $3.10
  • TSQ $12.32
  • Technical
  • Relative Strength Index (RSI)
  • CLLS 69.22
  • TSQ 36.65
  • Support Level
  • CLLS $2.43
  • TSQ $7.17
  • Resistance Level
  • CLLS $3.10
  • TSQ $7.45
  • Average True Range (ATR)
  • CLLS 0.27
  • TSQ 0.37
  • MACD
  • CLLS 0.08
  • TSQ -0.14
  • Stochastic Oscillator
  • CLLS 88.72
  • TSQ 0.40

About CLLS Cellectis S.A.

Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.

About TSQ Townsquare Media Inc.

Townsquare Media Inc is a radio, digital media, entertainment, and digital marketing solutions company principally focused on being the premier local advertising and marketing solutions platform in small and mid-sized markets across the United States. It has three segments which are Subscription Digital Marketing Solutions, Digital Advertising, and Broadcast Advertising. It earns the majority of the revenue from the Broadcasting Advertising segment, which includes its local, regional, and national advertising products and solutions delivered via terrestrial radio broadcast. Its portfolio includes local media brands such as WYRK.com, WJON.com, and NJ101.5.com, and premier national music brands such as XXLmag.com, TasteofCountry.com, UltimateClassicRock.com, and Loudwire.com.

Share on Social Networks: